Zhanyu Wang

KRAS‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer

N. Sun, Q. Xue, Yan Wang, 2022, Cancer communications.